Significant up-regulation of the markers that participate in both leukocyte trafficking and angiogenesis (e.g., CX3CL1, CCR1, CD47, VCAM-1, ICAM-1, PECAM1 and ICAM2) is noted in DM patients (Fig. 3). This evidence concerns the gene VCAM1 and dermatomyositis.